- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05954676
Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery
Effects of Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Recruiting
- Washington University School of Medicine
-
Contact:
- Jason Rich, M.D.
- Phone Number: 314-747-3742
- Email: richj@wustl.edu
-
Contact:
- Thomas Barrett, M.D.
- Phone Number: 314-448-3321
- Email: tfbarrett@wustl.edu
-
Principal Investigator:
- Jason Rich, M.D.
-
Sub-Investigator:
- Thomas Barrett, M.D.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older
- Have had or are undergoing free flap surgery and/or total laryngetomy
- Have internet access
- English speaking
Exclusion Criteria:
- Younger than 18 years of age
- No internet access
- Non-English speaking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CareOrbit - Patients
Patients will be assigned a username and password to access their CareOrbit account via the internet (caregivers will use the same account information). These patients may designate up to 3 additional individuals who will be participating in the patient's postoperative care to receive the link along with a unique username and password via email. All patients will additionally receive standard pre- and post-operative instructions and care. This will include verbal education by the surgeons at their pre-operative visits. Patient questionnaires will be distributed at the first and second post-operative visits (typically 1-2 weeks after discharge and 3 months after post-operative clinic visit). At 30 days following discharge, the patients' medical records will be reviewed by the study team to assess for the primary or secondary outcomes. Patients will be contacted by telephone to inquire about ED/UC visits outside of the BJC system. |
CareOrbit is a third-party organization that provides a HIPAA-compliant, patient-centered digital engagement platform that helps create, organize, and update content to educate and serve the patient and caregivers through their entire treatment journey.
|
|
Experimental: CareOrbit - Caregivers
Patients will be assigned a username and password to access their CareOrbit account via the internet (caregivers will use the same account information). These patients may designate up to 3 additional individuals who will be participating in the patient's postoperative care to receive the link along with a unique username and password via email. All patients will additionally receive standard pre- and post-operative instructions and care. This will include verbal education by the surgeons at their pre-operative visits. Patient questionnaires will be distributed at the first and second post-operative visits (typically 1-2 weeks after discharge and 3 months after post-operative clinic visit). At 30 days following discharge, the patients' medical records will be reviewed by the study team to assess for the primary or secondary outcomes. Patients will be contacted by telephone to inquire about ED/UC visits outside of the BJC system. |
CareOrbit is a third-party organization that provides a HIPAA-compliant, patient-centered digital engagement platform that helps create, organize, and update content to educate and serve the patient and caregivers through their entire treatment journey.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
30-day readmission
Time Frame: At Day 30
|
At Day 30
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of emergency room/urgent care visits
Time Frame: Through 3 months post-operative
|
Through 3 months post-operative
|
|
|
Number of unplanned clinic visits
Time Frame: Through 3 months post-operative
|
Through 3 months post-operative
|
|
|
Number of telephone calls/electronic messages to clinic staff
Time Frame: Through 3 months post-operative
|
Through 3 months post-operative
|
|
|
Satisfaction of education
Time Frame: At pre-operative visit, 2 weeks post-operative, and 3 months post-operative
|
Participants will complete a survey asking satisfaction of the educational material.
Answers range from 1=excellent to 5=poor.
A higher score indicates a higher level of satisfaction.
|
At pre-operative visit, 2 weeks post-operative, and 3 months post-operative
|
|
Preparedness for head and neck surgery and post-operative care
Time Frame: At pre-operative visit, 2 weeks post-operative, and 3 months post-operative
|
Participants will complete a survey asking satisfaction of the educational material.
Answers range from 1=excellent to 5=poor.
A higher score indicates a higher level of preparedness.
|
At pre-operative visit, 2 weeks post-operative, and 3 months post-operative
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jason Rich, M.D., Washington University School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201909127
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Cancer
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
Mayo ClinicCompletedCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
West China HospitalNot yet recruitingHead and Neck Cancer | Malignant Neoplasm | Advanced Head and Neck Carcinoma | Head &Amp; Neck Cancer
-
National Cancer Institute (NCI)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
Fondazione IRCCS Policlinico San Matteo di PaviaNestle Health Science; Akern SrlCompletedHead-neck CancerItaly
-
Radboud University Medical CenterUnknown
-
University of California, San FranciscoCompleted
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR)RecruitingAdvanced Head and Neck CancerCanada
-
Centre Oscar LambretCompletedEpidermoid Head and Neck CancerFrance